Skip to content

A Study to Estimate the Effect of Multiple Doses of Carbamazepine on the PK of Single Dose Vepdegestrant in Healthy Adult Participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505881-27-00
Acronym
C4891011
Enrollment
12
Registered
2023-08-07
Start date
2023-08-14
Completion date
2023-11-21
Last updated
2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ER+/HER2 positive breast cancer

Interventions

None listed

Sponsors

Pfizer Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026